An intranasal vaccine will protect against chlamydia

Copper news based on UPI materials: Researchers identify potential vaccine for chlamydia

Specialists from McMaster University have developed an intranasal vaccine to prevent infection with chlamydia. Despite the fact that there are ways to treat infection and they allow you to effectively cope with chlamydia, this disease often proceeds asymptomatically and it cannot be detected in a timely manner. If left untreated, chlamydia can lead to fertility problems and blindness.

David Bulir explains that vaccination can be the most effective way of transmission of infection. The developers have already tested their development on mice. The vaccine containing the BD584 antigen really protected rodents from chlamydia, and also significantly reduced the likelihood of complications. Thus, the risk of hydrosalpinx, a violation of the patency of the fallopian tubes, interfering with fertilization, decreased by 87.5%.

In the near future, scientists are going to test how the vaccine copes with different chlamydia strains, as well as experiment with the composition of the vaccine, making it safe and effective.

The vaccine is supposed to be administered intranasally – this method does not injure the patient, and in addition, does not require high qualification and special training of medical personnel. The developers believe that a vaccine against chlamydia will be inexpensive and therefore will be widely distributed even in developing countries.

The article by Bulir et al. Immunization with chlamydial type III secret antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge is published in the journal Vaccine – VM.

Portal "Eternal Youth" http://vechnayamolodost.ru  21.07.2016